MFAP4 and myocardial ischemia: Remarkably, circulating MFAP4 levels were gradually decreasing following the developed degree of myocardial ischemia, which were lowest in the STEMI group (STEMI vs. non-STEMI p = 0.018 and STEMI vs. UA p < 0.001, respectively). Medication on admission and medication on discharge is shown in Table S1.